GAZYVA belongs to a group of anti-cancer) agents called monoclonal antibodies. Monoclonal antibodies are proteins which specifically recognise and bind to other unique proteins in the body.GAZYVA is used to treat chronic lymphocytic leukaemia (CLL). It is also used to treat Non-Hodgkin’s follicular lymphoma (FL) when FL is no longer responsive to treatment with another medicine called rituximab.
GAZYVA recognises and attaches to a protein called CD20 which is found on the surface of white blood cells known as B lymphocytes. During the process of binding to the protein, the abnormal growth of the B lymphocytes is stopped.
It is the abnormally growing B lymphocytes that are responsible for CLL and FL.
For CLL GAZYVA is used with the chemotherapy medicine chlorambucil. For FL GAZYVA is
used with the chemotherapy medicine bendamustine. For further information about chlorambucil or Bendamustine please ask your doctor, nurse or pharmacist for the Consumer Medicine Information (CMI) for these medicines.
"If my lymphoma relapses I hope I can have access to the best available treatment for me"